Inflection Point Acquisition Corp. V
IPEX evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for IPEX—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Financial data as of Mar 31, 2026.
Run Inflection Point Acquisition Corp. V through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Inflection Point Acquisition Corp. V facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
0.9 months
OCF -$215K · Net income $240K
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Runway
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
29
Total value held
$41.1M
| Holder | Shares | Value |
|---|---|---|
| berkley w r corp | 981,096 | $10.2M |
| mizuho securities usa llc | 455,453 | $4.7M |
| wolverine asset management llc | 356,434 | $3.7M |
| shaolin capital management llc | 230,425 | $2.4M |
| d. e. shaw & co., inc. | 200,000 | $2.1M |
| dld asset management, lp | 200,000 | $2.1M |
| toronto dominion bank | 170,000 | $1.8M |
| hudson bay capital management lp | 150,000 | $1.6M |
| whitebox advisors llc | 125,000 | $1.3M |
| tenor capital management co., l.p. | 125,000 | $1.3M |
Showing top 10 of 29 institutional holders of Inflection Point Acquisition Corp. V. Open the full 13F history after sign-in.
Short Interest
as of Apr 30, 2026- % of float
- 0.1%
- Days to cover
- 0.3
- Shares short
- 5,007
- Daily short volume (Jun 18, 2026)
- 8.4%
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
IPEX short interestGovernance
Frequently asked questions
Who is the CEO of Inflection Point Acquisition Corp. V?
Mr. Michael Blitzer is the chief executive officer of Inflection Point Acquisition Corp. V (IPEX).
Where is Inflection Point Acquisition Corp. V headquartered?
Inflection Point Acquisition Corp. V (IPEX) is headquartered in New York, NY, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.